Numinus Says FDA Decision on New Therapy "A Blow", But Adds It Is Not Dependent On New Therapies; Also Terminated LoI With MedBright AI

Numinus表示FDA对新疗法的决定是一个打击，但补充说不依赖新疗法；此外已经终止与MedBright AI的意向书。

MT Newswires · 08/12 07:38

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Numinus Says FDA Decision on New Therapy "A Blow", But Adds It Is Not Dependent On New Therapies; Also Terminated LoI With MedBright AI

Numinus Says FDA Decision on New Therapy "A Blow", But Adds It Is Not Dependent On New Therapies; Also Terminated LoI With MedBright AI

风险及免责提示

声明